FDA Approves Ketamine-Like Drug for Severe Depression

WEDNESDAY, March 6, 2019 — The U.S. Food and Drug Administration on Tuesday approved the nasal spray medication esketamine — a relative of the club drug and anesthetic ketamine — for use against severe depression.
Sold as Spravato, the…
Source: Topamax